In today’s fast-paced world, respiratory issues have become increasingly common, affecting individuals of all ages. Whether it’s due to environmental pollutants, allergens, or chronic conditions like ...
Background Whether inhaled corticosteroids (ICSs) reduce major adverse cardiovascular events (MACEs) in people with chronic obstructive pulmonary disease (COPD) is debated. Objectives To establish, ...
It’s not necessary to treat all MS flare-ups with steroids, though. These medications are generally reserved for severe flare-ups that interfere with your ability to function. Some symptoms of ...
In patients with chronic obstructive pulmonary disease (COPD), the first year of using single-inhaler triple therapy is associated with slightly more major adverse cardiovascular events (MACE) than ...
“We are proud to continue advancing our asthma and COPD inhaled drug program, achieving key clinical development milestones on schedule,” said Xian-Ming Zeng, Ph.D., CEO of Transpire Bio.
13, 2025 (GLOBE NEWSWIRE) -- Transpire Bio Inc., an integrated clinical-stage biopharmaceutical company dedicated to developing inhaled medicines, today announced the commencement of a new human ...